HEADER ANTIMICROBIAL PROTEIN 23-SEP-11 2LJT TITLE C9L,C14L-LEUA COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACTERIOCIN LEUCOCIN-A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LEUCOCIN A-UAL 187, LEU A; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEUCONOSTOC GELIDUM; SOURCE 3 ORGANISM_TAXID: 1244; SOURCE 4 STRAIN: UAL 187; SOURCE 5 GENE: LCNA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PMAL-C2X KEYWDS ANTIMICROBIAL PEPTIDE, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.S.SIT,C.T.LOHANS,M.J.VAN BELKUM,C.D.CAMPBELL,M.MISKOLZIE, AUTHOR 2 J.C.VEDERAS REVDAT 3 14-JUN-23 2LJT 1 SEQADV REVDAT 2 18-JAN-12 2LJT 1 JRNL REVDAT 1 11-JAN-12 2LJT 0 JRNL AUTH C.S.SIT,C.T.LOHANS,M.J.VAN BELKUM,C.D.CAMPBELL,M.MISKOLZIE, JRNL AUTH 2 J.C.VEDERAS JRNL TITL SUBSTITUTION OF A CONSERVED DISULFIDE IN THE TYPE IIA JRNL TITL 2 BACTERIOCIN, LEUCOCIN A, WITH L-LEUCINE AND L-SERINE JRNL TITL 3 RESIDUES: EFFECTS ON ACTIVITY AND THREE-DIMENSIONAL JRNL TITL 4 STRUCTURE. JRNL REF CHEMBIOCHEM V. 13 35 2012 JRNL REFN ISSN 1439-4227 JRNL PMID 22121114 JRNL DOI 10.1002/CBIC.201100634 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1, CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LJT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000102468. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 90 % [U-2H] TFE, 10 % H2O, 0.1 % REMARK 210 TFA, 2.6 MM DSS, REMARK 210 TRIFLUOROETHANOL/WATER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-13C HSQC; 2D 1H-15N HSQC; REMARK 210 3D HNHA; 3D CBCA(CO)NH; 3D HCCH- REMARK 210 TOCSY; 3D HNCO; 3D HNCACB; 3D 1H- REMARK 210 13C NOESY; 3D 1H-15N NOESY; 3D REMARK 210 1H-15N TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : VNMRS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : ALL CALCULATED STRUCTURES REMARK 210 SUBMITTED REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 3 ASN A 5 88.96 -161.96 REMARK 500 8 ASN A 5 -74.43 -69.14 REMARK 500 9 PHE A 36 -70.69 -90.62 REMARK 500 12 ASN A 34 -62.34 -90.30 REMARK 500 16 ASN A 5 -70.73 -76.36 REMARK 500 19 ASN A 5 83.97 -161.86 REMARK 500 20 ASN A 5 85.17 -69.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17958 RELATED DB: BMRB REMARK 900 RELATED ID: 2LJQ RELATED DB: PDB DBREF 2LJT A 1 37 UNP P34034 LCCA_LEUGE 25 61 SEQADV 2LJT LEU A 9 UNP P34034 CYS 33 ENGINEERED MUTATION SEQADV 2LJT LEU A 14 UNP P34034 CYS 38 ENGINEERED MUTATION SEQRES 1 A 37 LYS TYR TYR GLY ASN GLY VAL HIS LEU THR LYS SER GLY SEQRES 2 A 37 LEU SER VAL ASN TRP GLY GLU ALA PHE SER ALA GLY VAL SEQRES 3 A 37 HIS ARG LEU ALA ASN GLY GLY ASN GLY PHE TRP HELIX 1 1 GLY A 6 ASN A 31 1 26 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1